| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.05 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.28 | 0.05 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.31 | 0.05 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |